Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment
- PMID: 28301217
- DOI: 10.1080/00952990.2017.1295459
Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment
Erratum in
-
Corrigendum.Am J Drug Alcohol Abuse. 2018;44(4):498. doi: 10.1080/00952990.2018.1462065. Epub 2018 Apr 11. Am J Drug Alcohol Abuse. 2018. PMID: 29641261 No abstract available.
Abstract
Background: Finding an effective, non-pharmacological approach to treat opioid withdrawal could remove some of the barriers associated with pharmacotherapy. The BRIDGE® is a noninvasive, percutaneous electrical nerve field stimulator developed to target pain.
Objectives: This pilot study aimed to determine (1) the effects of the BRIDGE on withdrawal scores during the induction phase of opioid withdrawal therapy, (2) the percentage of subjects who successfully transitioned to medication assisted therapy (MAT).
Methods: Adult patients treated with the BRIDGE during medically supervised withdrawal were included in this open label, uncontrolled, and retrospective study. The clinical opioid withdrawal scale (COWS) scores were prospectively recorded at different intervals (20, 30, and 60 min) and analyzed retrospectively. A subset of patients had scores recorded 5-days post-BRIDGE. Those who returned to the clinic and received their first dose of maintenance medication were considered to be successfully transitioned.
Results: In this cohort (n=73), 65% were male. The mean COWS score prior to BRIDGE placement was 20.1 (±6.1). Twenty minutes after BRIDGE placement, the mean score was reduced to 7.5 (±5.9) (62.7% reduction, p<0.001). The scores further decreased after 30 minutes 4.0 (±4.4) and 60 minutes 3.1 (±3.4) (84.6% reduction, p<0.001). No rescue medications were administered during this period. The mean withdrawal score on day 5 was 0.6 (97.1% reduction, p<0.001) (n=33). Overall, 64/73 patients (88.8%) successfully transitioned to MAT.
Conclusions: Neurostimulation with the BRIDGE is associated with a reduction in opioid withdrawal scores. This effect persisted during the induction period and allowed for effective transition to MAT.
Keywords: Addiction; auricular stimulation; neurostimulation; opioids; withdrawal; withdrawal scale.
Similar articles
-
A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.Am J Drug Alcohol Abuse. 2018;44(3):302-309. doi: 10.1080/00952990.2017.1334209. Epub 2017 Aug 10. Am J Drug Alcohol Abuse. 2018. PMID: 28795846
-
Delivering transcutaneous auricular neurostimulation (tAN) to improve symptoms associated with opioid withdrawal: results from a prospective clinical trial.Bioelectron Med. 2022 Aug 18;8(1):12. doi: 10.1186/s42234-022-00095-x. Bioelectron Med. 2022. PMID: 35978394 Free PMC article.
-
A randomized effectiveness trial of methadone, TENS and methadone plus TENS in management of opiate withdrawal symptoms.J Pak Med Assoc. 2008 Dec;58(12):667-71. J Pak Med Assoc. 2008. PMID: 19157318 Clinical Trial.
-
Reduction of opiate withdrawal symptoms with use of clonidine in a county jail.J Correct Health Care. 2015 Jan;21(1):27-34. doi: 10.1177/1078345814557630. Epub 2014 Nov 26. J Correct Health Care. 2015. PMID: 25431436 Review.
-
Acupuncture for Detoxification in Treatment of Opioid Addiction.East Asian Arch Psychiatry. 2016 Jun;26(2):70-6. East Asian Arch Psychiatry. 2016. PMID: 27377488 Review.
Cited by
-
Clinical Efficacy of Auricular Vagus Nerve Stimulation in the Treatment of Chronic and Acute Pain: A Systematic Review and Meta-analysis.Pain Ther. 2024 Dec;13(6):1407-1427. doi: 10.1007/s40122-024-00657-8. Epub 2024 Oct 9. Pain Ther. 2024. PMID: 39382792 Free PMC article. Review.
-
Managing Opioid Withdrawal Symptoms During the Fentanyl Crisis: A Review.Subst Abuse Rehabil. 2024 Apr 10;15:59-71. doi: 10.2147/SAR.S433358. eCollection 2024. Subst Abuse Rehabil. 2024. PMID: 38623317 Free PMC article. Review.
-
Percutaneous auricular neuromodulation (nerve stimulation) for the treatment of pain following cholecystectomy and hernia repair: a randomized, double-masked, sham-controlled pilot study.Reg Anesth Pain Med. 2024 Sep 2;49(9):628-634. doi: 10.1136/rapm-2024-105283. Reg Anesth Pain Med. 2024. PMID: 38388014 Free PMC article. Clinical Trial.
-
Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.Ann Depress Anxiety. 2023;10(1):1117. Epub 2023 Aug 2. Ann Depress Anxiety. 2023. PMID: 38074313 Free PMC article.
-
Neuroscientific Basis of Treatment for Substance Use Disorders.Noro Psikiyatr Ars. 2022 Dec 16;59(Suppl 1):S75-S80. doi: 10.29399/npa.28172. eCollection 2022. Noro Psikiyatr Ars. 2022. PMID: 36578985 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical